Infectious Disease

Sharon L. Hillier, PhD, discusses updates to digital CROI

March 05, 2021

1 min o’clock

Source / information

Published by:

Disclosure:
Hillier reports receiving advisory fees from Gilead Sciences and Merck.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

In preparation for the second all-virtual conference in a row on retroviruses and opportunistic infections, the organizers wanted to improve the digital components of the meeting, said the conference leader Sharon L. Hillier, PhD.

Last year’s meeting was abruptly converted to virtual format due to concerns about the spread of COVID-19.

“That experience – which was hair-raising and very difficult – taught us that we need to rethink the virtual format for this year’s CROI,” said Hillier, professor of obstetrics, gynecology and reproductive science, and microbiology and molecular genetics at the University of Pittsburgh Medical School.

In this video, Hillier talks about improvements to the virtual format of the meeting and the research developments that will be explored during CROI 2021.

“We look forward to a time when we can meet again in person and build real live networks,” said Hillier.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

Conference on Retroviruses and Opportunistic Infections (CROI)

Conference on Retroviruses and Opportunistic Infections (CROI)

Related Articles